FDA Update: WATCHMAN FLX Pro Left Atrial Appendage Closure Device
https://www.acc.org/latest-in-cardiology/articles/2023/09/07/12/43/fda-update-watchman-flx-pro-left-atrial-appendage-closure-device-receives-fda-approval
WEBSep 7, 2023 · The WATCHMAN FLX Pro device includes several enhancements to the previous WATCHMAN FLX device design, which received FDA approval in July 2020, such as a thromboresistant coating, visualization markers and a larger size option, enabling clinicians to treat patients with larger left atrial appendages.
DA: 26 PA: 15 MOZ Rank: 14